BioSpace News Archive

A molecular building block of many animal proteins, the amino acid valine, plays a key role in cancerous growth seen in T cell acute lymphoblastic leukemia, a new study shows.

Dovetail Genomics today announced details of a new study, led by University of Michigan researchers and published in Nature.

Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for Pfizer’s Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the treatment of mild-to-moderate coronavirus disease (COVID-19).

Intellipharmaceutics International Inc. is issuing this press release in response to a request from the Investment Industry Regulatory Organization of Canada to comment on the recent trading activity of its stock.

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced the U.S. Food and Drug Administration’s (FDA) acceptance for review of the company’s new drug application (NDA) for roflumilast cream for the treatment of psoriasis in adults and adolescents.

Sol-Gel Technologies, Ltd. (Nasdaq: SLGL), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases, today announced that the Company will participate in the LifeSci Partners 11th Annual Corporate Access Event and the H.C. Wainwright BioConnect Conference.

Adagene Inc. (“Adagene”) (Nasdaq: ADAG), today announced achievement of a key milestone in its ongoing collaboration with Exelixis for development of novel masked antibody-drug conjugate (ADC) candidates leveraging Adagene’s proprietary SAFEbody precision masking technology.

Sandoz, a global leader in generic and biosimilar medicines, today announced the US launch of its authorized generic of Narcan® (naloxone hydrochloride)* Nasal Spray 4mg, which is used to reverse opioid overdose.

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will virtually present at the 40th Annual J.P. Morgan Healthcare Conference via webcast.

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast its presentation at the 40th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2022.